89bio Valuation
| ETNB Stock | USD 9.14 0.24 2.70% |
At this time, the entity appears to be undervalued. 89bio Inc shows a prevailing Real Value of $14.81 per share. The current price of the entity is $9.14. Our model approximates the value of 89bio Inc from examining the entity fundamentals such as Return On Asset of -0.41, current valuation of 688.5 M, and Shares Owned By Institutions of 93.66 % as well as evaluating its technical indicators and probability of bankruptcy. Key fundamental drivers impacting 89bio's valuation include:
Price Book 2.8424 | Enterprise Value 688.5 M | Enterprise Value Ebitda (2.75) |
Undervalued
Today
Please note that 89bio's price fluctuation is somewhat reliable at this time. Calculation of the real value of 89bio Inc is based on 3 months time horizon. Increasing 89bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since 89bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of 89bio Stock. However, 89bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.14 | Real 14.81 | Target 33.44 | Hype 9.03 | Naive 9.23 |
The real value of 89bio Stock, also known as its intrinsic value, is the underlying worth of 89bio Inc Company, which is reflected in its stock price. It is based on 89bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of 89bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of 89bio Inc helps investors to forecast how 89bio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of 89bio more accurately as focusing exclusively on 89bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use 89bio's intrinsic value based on its ongoing forecasts of 89bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against 89bio's closest peers. If more than one evaluation category is relevant for 89bio we suggest using both methods to arrive at a better estimate.
89bio Cash |
|
89bio Valuation Trend
Comparing 89bio's enterprise value against its market capitalization is a good way to estimate the value of 89bio Inc uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
89bio Total Value Analysis
89bio Inc is currently estimated to have valuation of 688.5 M with market capitalization of 1.07 B, debt of 27.11 M, and cash on hands of 193.34 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the 89bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
688.5 M | 1.07 B | 27.11 M | 193.34 M |
89bio Asset Utilization
One of the ways to look at asset utilization of 89bio is to check how much profit was generated for every dollar of assets it reports. 89bio Inc shows a negative utilization of assets of -0.41 percent, losing $0.004136 for each dollar of assets held by the entity. Ineffective asset utilization signifies that the company is being less productive with each dollar of assets it shows. Put another way, asset utilization of 89bio Inc shows how unsuccessful it operates for each dollar spent on its assets.89bio Ownership Allocation
89bio holds a total of 117.58 Million outstanding shares. The majority of 89bio Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in 89bio Inc to benefit from reduced commissions. Thereupon, institutional investors are subject to a different set of regulations than regular investors in 89bio. Please pay attention to any change in the institutional holdings of 89bio Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.89bio Profitability Analysis
Net Loss for the year was (142.19 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates 89bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in 89bio and how it compares across the competition.
About 89bio Valuation
The stock valuation mechanism determines 89bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of 89bio. We calculate exposure to 89bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of 89bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -273 K | -259.4 K |
89bio Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 71.2 M |
89bio Current Valuation Indicators
Valuation refers to the process of determining the present value of 89bio Inc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value 89bio we look at many different elements of the entity such as 89bio's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as 89bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use 89bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes 89bio's worth.Complementary Tools for 89bio Stock analysis
When running 89bio's price analysis, check to measure 89bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 89bio is operating at the current time. Most of 89bio's value examination focuses on studying past and present price action to predict the probability of 89bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 89bio's price. Additionally, you may evaluate how the addition of 89bio to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |